- $1.67bn
- $1.78bn
- $2.38bn
- 90
- 47
- 91
- 90
Annual income statement for Rev, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,278 | 2,381 | 2,332 | 2,638 | 2,380 |
| Cost of Revenue | |||||
| Gross Profit | 228 | 291 | 248 | 316 | 297 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,298 | 2,308 | 2,295 | 2,551 | 2,011 |
| Operating Profit | -20.4 | 73 | 36.9 | 86.8 | 369 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -46.1 | 55.7 | 19.8 | 58.2 | 340 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -34 | 40.2 | 15.2 | 45.3 | 258 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -30.5 | 44.4 | 15.2 | 45.3 | 258 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -30.5 | 44.4 | 15.2 | 45.3 | 258 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.387 | 1.11 | 0.881 | 1.46 | -0.835 |
| Dividends per Share |